Clinical Study
Doxapram Use for Apnoea of Prematurity in Neonatal Intensive Care
| | (%) | Median (IQR) (min–max) |
| Success rate of doxapram | 79/116 (64.8%) | | Route of administration (IV/oral/both) | 58 (49.2)/49 (41.5)/11 (9.3) | | Number of doxapram episodes (1/2/3) | 92 (75.4)/29 (23.8)/1 (0.8) | | Postnatal age (days) | | 13.5 (11) (1–40) | Total duration of doxapram use (hrs) | | 108 (147) (0.5–698) | Average dose of doxapram (mg/kg/hour) | | 1.07 (0.66) (0.32–5.44) | Cumulative dose doxapram | | 116 (186) (0.3–859.6) | Cumulative dose doxapram (per kg) | | 109.5 (174.2) (0.33–781.5) |
|
|